The final 2022 American College of Rheumatology/EULAR Classification Criteria for Giant Cell Arteritis. Credit: Annals of the Rheumatic Diseases (2022). DOI: 10.1136/ard-2022-223480 Giant cell ...
TORONTO — The lack of clinical trials testing the efficacy of treatments for axial disease in juvenile spondyloarthritis (axJSpA) remains a large unmet need, according to experts. Now, the first-ever, ...
APS is a systemic autoimmune disease associated with persistent antiphospholipid antibodies (aPL). It can cause thrombosis and pregnancy complications as well as non-thrombotic manifestations such as ...
TORONTO — After almost 10 years, the much-anticipated revision of the current classification criteria for axial spondyloarthritis (axSpA) is ready for prime time. An abstract of the modified criteria ...
At present, classifying hand osteoarthritis (OA) is based on clinical findings, and available tools are not able to distinguish between certain phenotypes. With new disease-modifying treatments in ...
HA is distinctive arthropathy associated with genetic haemochromatosis – a condition where iron levels build up over time. This has many consequences, including liver cirrhosis, diabetes, and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results